Evaluating patients at-risk for antinuclear antibodies-associated systemic autoimmune rheumatic disease particularly systemic lupus erythematosus, Sjogren syndrome, and mixed connective tissue disease. ANA may rarely also be detectable following viral illnesses, in chronic infections, or in patients treated with many different medications.